- Title: Subtitle
- 507 - Prophylactic Corticosteroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/ Refractory Large B-Cell Lymphoma (R/R LBCL): 2-Year Follow-up of Zuma-1 Cohort 6
- Creators
- Olalekan O. OluwoleEdouard ForcadeJavier MuñozSophie de GuibertJulie M. VoseNancy L. BartlettYi LinAbhinav DeolPeter A. McSweeneyAndre H. GoyMarie José KerstenCaron A. JacobsonUmar FarooqMonique C. MinnemaCatherine ThieblemontJohn M. TimmermanPatrick StiffIrit AviviDimitrios TzachanisYan ZhengSaran VardhanabhutiJenny NaterRhine R. ShenHarry MiaoJenny J. KimTom van Meerten
- Resource Type
- Abstract
- Publication Details
- Transplantation and cellular therapy, Vol.29(2 Suppl.), pp.S379-S380
- DOI
- 10.1016/S2666-6367(23)00575-4
- ISSN
- 2666-6367
- eISSN
- 2666-6367
- Publisher
- Elsevier Inc
- Language
- English
- Date published
- 02/2023
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
- Record Identifier
- 9984366359402771
Abstract
507 - Prophylactic Corticosteroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/ Refractory Large B-Cell Lymphoma (R/R LBCL): 2-Year Follow-up of Zuma-1 Cohort 6
Transplantation and cellular therapy, Vol.29(2 Suppl.), pp.S379-S380
02/2023
DOI: 10.1016/S2666-6367(23)00575-4
Details
Metrics
23 Record Views